Cargando…

Update on mesenchymal stem cell-based therapy in lupus and scleroderma

Current systemic therapies are rarely curative for patients with severe life-threatening forms of autoimmune diseases (ADs). During the past 15 years, autologous hematopoietic stem cell transplantation has been demonstrated to cure some patients with severe AD refractory to all other available thera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cras, Audrey, Farge, Dominique, Carmoi, Thierry, Lataillade, Jean-Jacques, Wang, Dan Dan, Sun, Lingyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631077/ https://www.ncbi.nlm.nih.gov/pubmed/26525582 http://dx.doi.org/10.1186/s13075-015-0819-7

Ejemplares similares

Prognostic Factors for Clinical Response in Systemic Lupus Erythematosus Patients Treated by Allogeneic Mesenchymal Stem Cells
por: Wen, Lihui, et al.
Publicado: (2019)

Expression of transforming growth factor β receptor II in mesenchymal stem cells from systemic sclerosis patients
por: Vanneaux, Valérie, et al.
Publicado: (2013)

A Long-Term Follow-Up Study of Allogeneic Mesenchymal Stem/Stromal Cell Transplantation in Patients with Drug-Resistant Systemic Lupus Erythematosus
por: Wang, Dandan, et al.
Publicado: (2018)

Stem Cell Therapy in Lupus
por: Yuan, Xinran, et al.
Publicado: (2022)

Non-Classical HLA Determinants of the Clinical Response after Autologous Stem Cell Transplantation for Systemic Sclerosis
por: Boukouaci, Wahid, et al.
Publicado: (2022)

Human umbilical cord-derived mesenchymal stem/stromal cells: a promising candidate for the development of advanced therapy medicinal products
por: Mebarki, Miryam, et al.
Publicado: (2021)

Umbilical Cord Mesenchymal Stem Cells for Inhibiting the Fibrosis and Autoimmune Development in HOCl-Induced Systemic Scleroderma Mouse Model
por: Jin, Xin, et al.
Publicado: (2021)

Anti-Ephrin Type-B Receptor 2 (EphB2) and Anti-Three Prime Histone mRNA EXonuclease 1 (THEX1) Autoantibodies in Scleroderma and Lupus
por: Azzouz, Doua F., et al.
Publicado: (2016)

Comparing HLA Shared Epitopes in French Caucasian Patients with Scleroderma
por: Azzouz, Doua F., et al.
Publicado: (2012)

Localized scleroderma: clinical spectrum and therapeutic update()
por: Careta, Mariana Figueiroa, et al.
Publicado: (2015)

Update on Management of Morphea (Localized Scleroderma) in Children
por: George, Renu, et al.
Publicado: (2020)

Mesenchymal Stromal Cells Based Therapy in Systemic Sclerosis: Rational and Challenges
por: Peltzer, Juliette, et al.
Publicado: (2018)

Regulatory B Cells Contribute to the Clinical Response After Bone Marrow-Derived Mesenchymal Stromal Cell Infusion in Patients With Systemic Sclerosis
por: Loisel, Séverine, et al.
Publicado: (2023)

Shrinking lung syndrome in systemic lupus erythematosus-scleroderma overlap
por: Guleria, Vivek S., et al.
Publicado: (2014)

Synchronous Volvulus of the Transverse Colon and Cecum Associated with Scleroderma and Lupus
por: Manasewitsch, Nicholas T., et al.
Publicado: (2020)

Scleroderma with Nodular Scleroderma
por: Srisuttiyakorn, Chutika, et al.
Publicado: (2016)

Capillary Regeneration in Scleroderma: Stem Cell Therapy Reverses Phenotype?
por: Fleming, Jo N., et al.
Publicado: (2008)

Update on the pathogenesis of Scleroderma: focus on circulating progenitor cells
por: Brunasso, Alexandra Maria Giovanna, et al.
Publicado: (2016)

Clinical and Histopathological Features of Scleroderma-like Disorders: An Update
por: Foti, Rosario, et al.
Publicado: (2021)

Long-Lasting Inhibitory Effects of Fetal Liver Mesenchymal Stem Cells on T-Lymphocyte Proliferation
por: Giuliani, Massimo, et al.
Publicado: (2011)

Brachio-cervical inflammatory myopathy with associated scleroderma phenotype and lupus serology
por: Gao, Andrew F., et al.
Publicado: (2017)

Scleroderma-Like Lupus Panniculitis: A Case Report and Literature Review
por: Pinyowiwat, Prinpat, et al.
Publicado: (2023)

Mesenchymal stem cell therapy induces FLT3L and CD1c(+) dendritic cells in systemic lupus erythematosus patients
por: Yuan, Xinran, et al.
Publicado: (2019)

The Scleroderma Patient-centered Intervention Network for conducting large-scale international trials of nonpharmacological interventions in scleroderma: a way ahead for lupus?
por: Thombs, Brett D
Publicado: (2014)

The Therapeutic Effects of Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells on Scleroderma
por: Yu, Yue, et al.
Publicado: (2021)

Correction: Capillary Regeneration in Scleroderma: Stem Cell Therapy Reverses Phenotype?
por: Fleming, Jo N., et al.
Publicado: (2008)

Mesenchymal stem cell transplantation alleviated atherosclerosis in systemic lupus erythematosus through reducing MDSCs
por: Yao, Genhong, et al.
Publicado: (2022)

Scleroderma renal crisis: Case reports and update on critical issues
por: Zanatta, Elisabetta, et al.
Publicado: (2021)

Renal Disease and Systemic Sclerosis: an Update on Scleroderma Renal Crisis
por: Cole, Alice, et al.
Publicado: (2022)

Linear scleroderma occurring in a patient with systemic lupus erythematosus--short report.
por: Lee, C. W., et al.
Publicado: (1994)

Update on mesenchymal stem cell therapies for cartilage disorders
por: Paschos, Nikolaos K, et al.
Publicado: (2017)

Mesenchymal Stem Cells Control Complement C5 Activation by Factor H in Lupus Nephritis
por: Ma, Haijun, et al.
Publicado: (2018)

Association of TNF-α with Impaired Migration Capacity of Mesenchymal Stem Cells in Patients with Systemic Lupus Erythematosus
por: Geng, Linyu, et al.
Publicado: (2014)

Mesenchymal Stem Cell Therapy: Hope for Patients With Systemic Lupus Erythematosus
por: Li, Aifen, et al.
Publicado: (2021)

Scleroderma
Publicado: (1890)

Soluble HLA-G Expression Inversely Correlates With Fetal Microchimerism Levels in Peripheral Blood From Women With Scleroderma
por: Di Cristofaro, Julie, et al.
Publicado: (2018)

Stem Cell Therapy in the Treatment of Rheumatic Diseases and Application in the Treatment of Systemic Lupus Erythematosus
por: Leung, Patrick S. C., et al.
Publicado: (2016)

Serum IFN‐γ Predicts the Therapeutic Effect of Mesenchymal Stem Cells Transplantation in Systemic Lupus Erythematosus Patients
por: Wang, Dandan, et al.
Publicado: (2017)

Checkpoint Inhibitor-Associated Scleroderma and Scleroderma Mimics
por: Macklin, Michael, et al.
Publicado: (2023)

Scurvy presenting as pseudo-scleroderma of the leg
por: Ahangari, Dario, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jilk7hahnc7ksis6ca8titsura